-+ 0.00%
-+ 0.00%
-+ 0.00%

MDxHealth Q3 Operating Loss Widens 86% to USD 8.13 Million

PUBT·11/12/2026 21:01:33
Listen to the news
MDxHealth Q3 Operating Loss Widens 86% to USD 8.13 Million
  • MDxHealth’s third-quarter 2026 net loss widened 26% year over year to $12.26 million.
  • Revenue fell to $22.71 million, while operating loss widened 86% to $8.13 million year over year.
  • Higher operating expenses related to the ExoDx acquisition drove the wider operating loss.
  • The company eliminated its chief commercial officer role, with sales and marketing now reporting directly to the CEO.
  • Management expects a fully staffed, well-trained sales organization by fourth-quarter end, positioning the business to return to growth in 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MDxHealth SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611121600PRIMZONEFULLFEED1001303159) on November 12, 2026, and is solely responsible for the information contained therein.